What is the clinical evidence from this study?

Study design: Observational. Population: Non-dysferlin Miyoshi myopathy. Intervention: Non-dysferlin Miyoshi myopathy. Primary outcome: Cell membrane repair defects.

October 18, 2006TrafficOpen Access

Patients with a Non‐dysferlin Miyoshi Myopathy have a Novel Membrane Repair Defect

View Full Paper

Ask AI

Bookmark

Key result

Cells from patients with non-dysferlin Miyoshi myopathy exhibited membrane repair defects correlating with disease severity, despite lacking defects in conventional repair pathways.

Authors

JJJyoti K. JaiswalChildren's National GMGareth MarlowCardiff University GSGillian SummerillDurham University

Discussion

Member takes

Implication

Should not yet change Miyoshi myopathy management; leaves open novel non-conventional repair pathways for targeted research.

Study Design

Type

Observational

PICO

Population

Patients from a single family with non-dysferlin Miyoshi myopathy whose cells were analyzed for membrane repair defects.

Exposure / Comparator

Non-dysferlin Miyoshi myopathy

Primary Outcome

Cell membrane repair defects

Cite This Study

Jaiswal et al. (2006) conducted an observational in Non-dysferlin Miyoshi myopathy. Non-dysferlin Miyoshi myopathy was evaluated on Cell membrane repair defects. Cells from patients with non-dysferlin Miyoshi myopathy exhibited membrane repair defects correlating with disease severity, despite lacking defects in conventional repair pathways.

synapsesocial.com/papers/6a95c415fbedde85bb420ed7 https://doi.org/10.1111/j.1600-0854.2006.00505.x

View Full Paper

Ask AI

Bookmark

Patients with a Non‐dysferlin Miyoshi Myopathy have a Novel Membrane Repair Defect

Discussion

Member takes

Implication

Study Design

PICO

Cite This Study

Patients with a Non‐dysferlin Miyoshi Myopathy have a Novel Membrane Repair Defect

Discussion

Member takes

Implication

Study Design

PICO

Cite This Study

Also Consider

Also Consider